According to a review in the journal Amino Acids, collagen peptide supplementation (COL) in conjunction with exercise, has been shown to help support healthy joint functionality for people with degenerative bone and joint problems. Collagen peptides are a critical element of extracellular connective tissue, making up one-third of the total proteins in the human body.Read
This new animal study shows that a new technique for regenerative hydrogels could be the next new tool for joint diseases, such as knee osteoarthritis. Conventional treatments like artificial joint replacements offer temporary relief but come with several disadvantages, including limited functionality and the need for replacement. A better solutionRead
Plant extracts may not be as potent as taking ibuprofen for osteoarthritis. Their subtlety is a positive says, Michael Jurgelewicz, DC. “They have an action that spreads across multiple enzyme systems, which is often a better way to go because you get the effect you want without the potential downstream side effects such as edema, hypertension, ulceration, or renal dysfunction,” he writes.
According to a study by University of Toronto, the adult offspring of parents who were addicted to drugs or alcohol are more likely to have arthritis. Investigators examined a group of 13,036 adults and found that 20.4 per cent of respondents had been diagnosed with arthritis by a medical professional. Investigators found that 14.5 per cent of all respondents reported having at least one parent whose drug or alcohol use caused problems while were under the age of 18 and still living at home. The Association between a History of Parental Addictions and Arthritis in Adulthood: Findings from a Representative Community Survey, published in International Journal of Population Research, Volume 2014
In May 2013, Harvard Medical School published a report on osteoarthritis in their Women’s Health Watch. In the report, they looked at “on-the-horizon therapies” that could change the way you treat the disease. In the report, Dr. Anonios Aliprantis made statement that should have made doctor’s rethink the way they treat OA. “We’re beginning to understand that osteoarthritis is a disease of the entire joint,” said Aliprantis, director of the Osteoarthritis Center at Harvard-affiliated Brigham and Women’s Hospital. “Much of the research over the last 20 or 30 years has focused on cartilage as the target. But we’re beginning to realize that there are important changes happening in the bone underneath the cartilage, and in the joint lining itself. As we begin to understand osteoarthritis as a disease of the entire joint, new treatment targets will emerge.”
This archived case study Dan Lukaczer, ND is a useful model for practitioners seeking to develop a nutritional approach to treating arthritic symptoms. As Lukaczer points out in this case study, the relationship between rheumatoid arthritis [or any form of arthritis] and the myriad potential environmental triggers is beyond the scope of this report. Instead, this paper addresses the use of a focused nutritional support program and discusses select environmental influences to illustrate the rationale behind this clinical approach. Given the complexity of RA, no one approach can benefit all patients, but it is hoped that the case illustrated here will show how a nutritional program can be personalized, leading to a clinically-beneficial result. Registered users and Today’s Practitioner members can access the entire case study.
Integrative Nutritional Approach to the Treatment of Rheumatoid Arthritis, Published in Integrative Medicine, A Clinician’s Journal Vol. 4, No. 2 by Dan Lukaczer, ND
OPINION Dietary habits have been shown to influence the metabolic and inflammatory processes involved in Osteoarthritis (OA). Lower intake of antioxidants is associated with increased incidence of OA while an increased intake of flavonoids and omega-3 polyunsaturated acids decreases production of inflammatory mediators and the incidence of OA. This report will focus on the detailed preclinical and clinical investigation of flavocoxid, an anti-inflammatory medical food composition marketed for the metabolic management of OA. Published in Nutrition and Dietary Supplements, May 2010, by Robert Levy, Lakshmi Pillai and Bruce Burnett.